Tags

Type your tag names separated by a space and hit enter

Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.

Abstract

OBJECTIVE

To measure the levels of various cytokines, cytokine receptors, and cytokine antagonists in the synovial fluid of patients with temporomandibular disorders (TMD) and to determine the correlations among these expression levels.

STUDY DESIGN

Synovial fluid was obtained from 55 patients with TMD and from 5 asymptomatic healthy volunteers as controls. The concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1beta, soluble tumor necrosis factor receptors I and II (sTNFR-I and sTNFR-II), IL-6 soluble receptor (IL-6sR), IL-1 soluble receptor type II, and IL-1 receptor antagonist were determined by enzyme-linked immunosorbent assay.

RESULTS

The concentrations of TNF-alpha, IL-6, IL-1beta, sTNFR-I, and sTNFR-II were significantly higher in the synovial fluid of patients than in controls (P < .05). TNF-alpha level was positively correlated with those of IL-6, sTNFR-I, and sTNFR-II. In particular, there was a highly significant positive correlation between sTNFR-I and sTNFR-II.

CONCLUSION

TNF and sTNFRs in the synovial fluid of patients with TMD may be important in the pathogenesis of these disorders.

Authors+Show Affiliations

Department of Oral and Maxillofacial Surgery, Kanazawa Medical University, Ishikawa-Ken, Japan. k-k@kanazawa-med.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15716832

Citation

Kaneyama, Keiseki, et al. "Analysis of Tumor Necrosis Factor-alpha, Interleukin-6, Interleukin-1beta, Soluble Tumor Necrosis Factor Receptors I and II, Interleukin-6 Soluble Receptor, Interleukin-1 Soluble Receptor Type II, Interleukin-1 Receptor Antagonist, and Protein in the Synovial Fluid of Patients With Temporomandibular Joint Disorders." Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 99, no. 3, 2005, pp. 276-84.
Kaneyama K, Segami N, Sun W, et al. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(3):276-84.
Kaneyama, K., Segami, N., Sun, W., Sato, J., & Fujimura, K. (2005). Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 99(3), 276-84.
Kaneyama K, et al. Analysis of Tumor Necrosis Factor-alpha, Interleukin-6, Interleukin-1beta, Soluble Tumor Necrosis Factor Receptors I and II, Interleukin-6 Soluble Receptor, Interleukin-1 Soluble Receptor Type II, Interleukin-1 Receptor Antagonist, and Protein in the Synovial Fluid of Patients With Temporomandibular Joint Disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(3):276-84. PubMed PMID: 15716832.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. AU - Kaneyama,Keiseki, AU - Segami,Natsuki, AU - Sun,Wei, AU - Sato,Jun, AU - Fujimura,Kazuma, PY - 2005/2/18/pubmed PY - 2005/4/23/medline PY - 2005/2/18/entrez SP - 276 EP - 84 JF - Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics JO - Oral Surg Oral Med Oral Pathol Oral Radiol Endod VL - 99 IS - 3 N2 - OBJECTIVE: To measure the levels of various cytokines, cytokine receptors, and cytokine antagonists in the synovial fluid of patients with temporomandibular disorders (TMD) and to determine the correlations among these expression levels. STUDY DESIGN: Synovial fluid was obtained from 55 patients with TMD and from 5 asymptomatic healthy volunteers as controls. The concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1beta, soluble tumor necrosis factor receptors I and II (sTNFR-I and sTNFR-II), IL-6 soluble receptor (IL-6sR), IL-1 soluble receptor type II, and IL-1 receptor antagonist were determined by enzyme-linked immunosorbent assay. RESULTS: The concentrations of TNF-alpha, IL-6, IL-1beta, sTNFR-I, and sTNFR-II were significantly higher in the synovial fluid of patients than in controls (P < .05). TNF-alpha level was positively correlated with those of IL-6, sTNFR-I, and sTNFR-II. In particular, there was a highly significant positive correlation between sTNFR-I and sTNFR-II. CONCLUSION: TNF and sTNFRs in the synovial fluid of patients with TMD may be important in the pathogenesis of these disorders. SN - 1079-2104 UR - https://www.unboundmedicine.com/medline/citation/15716832/Analysis_of_tumor_necrosis_factor_alpha_interleukin_6_interleukin_1beta_soluble_tumor_necrosis_factor_receptors_I_and_II_interleukin_6_soluble_receptor_interleukin_1_soluble_receptor_type_II_interleukin_1_receptor_antagonist_and_protein_in_the_synovial_fluid_of_patients_with_temporomandibular_joint_disorders_ DB - PRIME DP - Unbound Medicine ER -